O

Orgabio Holdings Bhd
KLSE:ORGABIO

Watchlist Manager
Orgabio Holdings Bhd
KLSE:ORGABIO
Watchlist
Price: 0.3 MYR Market Closed
Market Cap: 74.4m MYR
Section:
 

Relative Value

The Relative Value of one ORGABIO stock under the Base Case scenario is 0.55 MYR. Compared to the current market price of 0.3 MYR, Orgabio Holdings Bhd is Undervalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ORGABIO Relative Value
Base Case
0.55 MYR
Undervaluation 46%
Relative Value
Price
O
Worst Case
Base Case
Best Case

Valuation Multiples

0.6
P/S
P/S
Price to Sales
0.6
vs History
0
vs Industry
55
Median 3Y
1.1
Median 5Y
1.1
Industry
2
Forward
0.6
More Details
13.3
P/E
P/E
Price to Earnings
13.3
vs History
11
vs Industry
16
Median 3Y
18.9
Median 5Y
17.6
Industry
18.3
Forward
5.9
More Details
12.8
P/OCF
P/OCF
Price to OCF
12.8
vs History
18
vs Industry
10
Median 3Y
12.8
Median 5Y
12.8
Industry
11.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
6
Median 3Y
-12.9
Median 5Y
-12.3
Industry
14.2
More Details
1.2
P/B
P/B
Price to Book Value
1.2
vs History
0
vs Industry
32
Median 3Y
1.4
Median 5Y
1.4
Industry
1.7
More Details
0.7
EV/S
EV/S
Enterprise Value to Sales
0.7
vs History
0
vs Industry
58
Median 3Y
1
Median 5Y
1
Industry
3.1
Forward
0.7
More Details
4.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.3
vs History
0
vs Industry
41
Median 3Y
5.6
Median 5Y
5.6
Industry
6.9
More Details
7.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
7.1
vs History
0
vs Industry
19
Median 3Y
9.3
Median 5Y
9.1
Industry
11
Forward
4.2
More Details
9.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
9.4
vs History
13
vs Industry
16
Median 3Y
12.8
Median 5Y
12.2
Industry
13.4
Forward
5.6
More Details
14.7
EV/OCF
EV/OCF
Enterprise Value to OCF
14.7
vs History
16
vs Industry
11
Median 3Y
14.5
Median 5Y
14.5
Industry
11.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
0
Median 3Y
-15.6
Median 5Y
-15
Industry
12.1
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
0
vs Industry
32
Median 3Y
1.2
Median 5Y
1.3
Industry
1.7
More Details

Multiples Across Competitors

ORGABIO Competitors Multiples
Orgabio Holdings Bhd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
MY
Orgabio Holdings Bhd
KLSE:ORGABIO
74.4m MYR 0.6 13.3 7.1 9.4
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR 0 0 0 0
US
GE Vernova LLC
NYSE:GEV
184.4B USD 0 0 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 351.6 4 020.7 3 417.4 3 537.2
NL
Nepi Rockcastle NV
JSE:NRP
87.8B Zac 0 0 0 0
CH
Galderma Group AG
SIX:GALD
38.5B CHF 0 0 0 0
US
Reddit Inc
NYSE:RDDT
45.8B USD 24.1 131.2 156.2 165.7
US
Coupang Inc
F:788
35.8B EUR 1.2 107.8 28.8 47.3
MY
Talam Transform Bhd
KLSE:TALAMT
167.3B MYR 3 726 -10 828.9 45 247.1 45 443.7
US
CoreWeave Inc
NASDAQ:CRWV
38.8B USD 0 0 0 0
US
Symbotic Inc
NASDAQ:SYM
38.5B USD 17.1 -2 274.2 -1 133.7 -514.3
P/S Multiple
Revenue Growth P/S to Growth
MY
O
Orgabio Holdings Bhd
KLSE:ORGABIO
Average P/S: 686.8
0.6
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
12%
N/A
US
C
China Industrial Group Inc
OTC:CIND
351.6
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-3%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
18%
N/A
US
R
Reddit Inc
NYSE:RDDT
24.1
44%
0.5
US
Coupang Inc
F:788
1.2
16%
0.1
MY
T
Talam Transform Bhd
KLSE:TALAMT
3 726
N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Symbotic Inc
NASDAQ:SYM
17.1
22%
0.8
P/E Multiple
Earnings Growth PEG
MY
O
Orgabio Holdings Bhd
KLSE:ORGABIO
Average P/E: 1 068.3
13.3
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
53%
N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-5%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
86%
N/A
US
R
Reddit Inc
NYSE:RDDT
131.2
N/A N/A
US
Coupang Inc
F:788
107.8
118%
0.9
MY
T
Talam Transform Bhd
KLSE:TALAMT
Negative Multiple: -10 828.9 N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -2 274.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
MY
O
Orgabio Holdings Bhd
KLSE:ORGABIO
Average EV/EBITDA: 9 771.3
7.1
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
58%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 417.4
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-3%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
28%
N/A
US
R
Reddit Inc
NYSE:RDDT
156.2
N/A N/A
US
Coupang Inc
F:788
28.8
56%
0.5
MY
T
Talam Transform Bhd
KLSE:TALAMT
45 247.1
N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -1 133.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
MY
O
Orgabio Holdings Bhd
KLSE:ORGABIO
Average EV/EBIT: 9 840.7
9.4
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
99%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 537.2
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-4%
N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
39%
N/A
US
R
Reddit Inc
NYSE:RDDT
165.7
N/A N/A
US
Coupang Inc
F:788
47.3
77%
0.6
MY
T
Talam Transform Bhd
KLSE:TALAMT
45 443.7
N/A N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -514.3 N/A N/A

See Also

Summary
ORGABIO intrinsic value, competitors valuation, and company profile.
DCF Valuation
ORGABIO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ORGABIO stock valuation using valuation multiples.
Wall Street Estimates
ORGABIO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ORGABIO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 306,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.